Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Mar. 31, 2023 | Jun. 30, 2022 | |
Entity Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | Live Oak Crestview Climate Acquisition Corp. | ||
Entity Central Index Key | 0001848323 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Shell Company | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
Entity Small Business | true | ||
Entity File Number | 001-40832 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Address, Address Line One | 40 S Main Street | ||
Entity Address, Address Line Two | #2550 | ||
Entity Address, City or Town | Memphis | ||
Entity Address, Country | TN | ||
Entity Address, Postal Zip Code | 38103 | ||
City Area Code | 901 | ||
Local Phone Number | 685-2865 | ||
Document Transition Report | false | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
ICFR Auditor Attestation Flag | false | ||
Trading Symbol | LOCC | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | ||
Security Exchange Name | NYSE | ||
Entity Tax Identification Number | 86-2044161 | ||
Entity Public Float | $ 192.2 | ||
Auditor Name | WithumSmith+Brown, PC | ||
Auditor Firm ID | 100 | ||
Auditor Location | New York, New York | ||
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant [Member] | |||
Entity Information [Line Items] | |||
Trading Symbol | LOCC.U | ||
Title of 12(b) Security | Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant | ||
Security Exchange Name | NYSE | ||
Redeemable warrants [Member] | |||
Entity Information [Line Items] | |||
Trading Symbol | LOCC WS | ||
Title of 12(b) Security | Redeemable warrants | ||
Security Exchange Name | NYSE | ||
Common Class A [Member] | |||
Entity Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 20,000,000 | ||
Common Class B [Member] | |||
Entity Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 5,000,000 |
Balance Sheet
Balance Sheet - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 489,602 | $ 1,861,218 |
Prepaid expenses | 373,178 | 874,815 |
Total current assets | 862,780 | 2,736,033 |
Investments held in Trust Account | 202,487,473 | 200,004,310 |
Total Assets | 203,350,253 | 202,740,343 |
Current liabilities: | ||
Accounts payable | 31,666 | 116,923 |
Accrued expenses | 610,748 | |
Income tax payable | 270,120 | |
Franchise tax payable | 154,244 | 55,636 |
Total current liabilities | 456,030 | 783,307 |
Deferred legal fees | 1,576,175 | 150,000 |
Deferred underwriting commissions | 6,300,000 | 6,300,000 |
Total liabilities | 8,332,205 | 7,233,307 |
Commitments and Contingencies | ||
Class A common stock subject to possible redemption, $0.0001 par value; 20,000,000 shares at $10.10 and $10.00 per share as of December 31, 2022 and 2021 respectively | 201,963,110 | 200,000,000 |
Stockholders' Deficit: | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ||
Additional paid-in capital | ||
Accumulated deficit | (6,945,562) | (4,493,464) |
Total stockholders' deficit | (6,945,062) | (4,492,964) |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit | 203,350,253 | 202,740,343 |
Common Class A [Member] | ||
Stockholders' Deficit: | ||
Common Stock, Value | ||
Common Class B [Member] | ||
Stockholders' Deficit: | ||
Common Stock, Value | $ 500 | $ 500 |
Balance Sheet (Parenthetical)
Balance Sheet (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Preferred stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Preferred stock shares authorized | 1,000,000 | 1,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred stock shares outstanding | 0 | 0 |
Common Class A [Member] | ||
Temporary equity shares Outstanding | 20,000,000 | 20,000,000 |
Temporary equity par or stated value per share | $ 0.0001 | $ 0.0001 |
Temporary equity redemption price per share | 10.10 | 10 |
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 250,000,000 | 250,000,000 |
Common stock shares issued | 20,000,000 | 20,000,000 |
Common stock shares outstanding | 20,000,000 | 20,000,000 |
Common Class B [Member] | ||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 20,000,000 | 20,000,000 |
Common stock shares issued | 5,000,000 | 5,000,000 |
Common stock shares outstanding | 5,000,000 | 5,000,000 |
Non Redeemable Class A Ordinary Shares [Member] | ||
Common stock shares issued | 0 | 0 |
Common stock shares outstanding | 0 | 0 |
Statement of Operations
Statement of Operations - USD ($) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
General and administrative expenses | $ 873,724 | $ 2,431,152 |
General and administrative expenses - related party | 60,000 | 180,000 |
Franchise tax expenses | 55,635 | 204,299 |
Loss from operations | (989,359) | (2,815,451) |
Other income: | ||
Interest income from investments held in Trust Account | 4,310 | 2,882,855 |
Interest income from operating account | 2,075 | 7,728 |
Net income (loss) before income taxes | (982,974) | 75,132 |
Income tax expense | 0 | (564,120) |
Net loss | $ (982,974) | $ (488,988) |
Common Class A [Member] | ||
Other income: | ||
Weighted average shares outstanding of common stock, Basic | 5,944,272 | 20,000,000 |
Weighted average shares outstanding of common stock, Diluted | 5,944,272 | 20,000,000 |
Basic net loss per share | $ (0.09) | $ (0.02) |
Diluted net loss per share | $ (0.09) | $ (0.02) |
Common Class B [Member] | ||
Other income: | ||
Weighted average shares outstanding of common stock, Basic | 4,922,601 | 5,000,000 |
Weighted average shares outstanding of common stock, Diluted | 4,922,601 | 5,000,000 |
Basic net loss per share | $ (0.09) | $ (0.02) |
Diluted net loss per share | $ (0.09) | $ (0.02) |
Statement of Changes in Stockho
Statement of Changes in Stockholders' Deficit - USD ($) | Total | Additional Paid-In Capital [Member] | Accumulated Deficit [Member] | Common Class A [Member] | Common Class A [Member] Common Stock [Member] | Common Class B [Member] | Common Class B [Member] Common Stock [Member] |
Beginning Balance at Feb. 11, 2021 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
Beginning Balance (in shares) at Feb. 11, 2021 | 0 | 0 | |||||
Issuance of Class B common stock to Sponsor | 25,000 | 24,425 | $ 575 | ||||
Issuance of Class B common stock to Sponsor (in shares) | 5,750,000 | ||||||
Sale of private placement warrants to Sponsor in private placement | 7,000,000 | 7,000,000 | |||||
Fair value of Public Warrants included in the Units sold in the Initial Public Offering | 6,933,330 | 6,933,330 | |||||
Offering costs associated with issuance of Public and Private Placement Warrants | (617,213) | (617,213) | |||||
Contribution from Sponsor upon sale of Founder Shares to Anchor Investors | 6,834,884 | 6,834,884 | |||||
Forfeiture of Class B common stock | 0 | 75 | 0 | $ (75) | |||
Forfeiture of Class B common stock(shares) | (750,000) | ||||||
Increase in redemption value of Class A common stock subject to possible redemption amount | 23,685,991 | 20,175,501 | 3,510,490 | ||||
Net loss | (982,974) | 0 | (982,974) | ||||
Ending Balance at Dec. 31, 2021 | (4,492,964) | 0 | (4,493,464) | $ 0 | $ 500 | ||
Ending Balance (in shares) at Dec. 31, 2021 | 0 | 5,000,000 | |||||
Beginning Balance (in shares) at Dec. 31, 2021 | 20,000,000 | 5,000,000 | |||||
Increase in redemption value of Class A common stock subject to possible redemption amount | 1,963,110 | 1,963,110 | |||||
Net loss | (488,988) | (488,988) | |||||
Ending Balance at Dec. 31, 2022 | $ (6,945,062) | $ 0 | $ (6,945,562) | $ 0 | $ 500 | ||
Ending Balance (in shares) at Dec. 31, 2022 | 0 | 5,000,000 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (982,974) | $ (488,988) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Interest income from investments held in Trust Account | (4,310) | (2,882,855) |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (874,815) | 501,638 |
Accounts payable | 104,923 | (85,257) |
Accrued expenses | 520,082 | (610,748) |
Income tax payable | 270,120 | |
Franchise tax payable | 55,636 | 98,608 |
Deferred legal fees | 1,426,175 | |
Net cash used in operating activities | (1,181,458) | (1,771,307) |
Cash Flows from Investing Activities: | ||
Investment income released from Trust Account to pay for taxes | 399,691 | |
Cash deposited in Trust Account | (200,000,000) | |
Net cash provided by (used in) investing activities | (200,000,000) | 399,691 |
Cash Flows from Financing Activities: | ||
Proceeds from issuance of Class B common stock to Sponsor | 25,000 | |
Proceeds from note payable to related party | 125,500 | |
Offering costs paid | (3,982,324) | |
Repayment of note payable to related party | (125,500) | |
Proceeds received from initial public offering, gross | 200,000,000 | |
Proceeds received from private placement | 7,000,000 | |
Net cash provided by financing activities | 203,042,676 | |
Net change in cash and cash equivalents | 1,861,218 | (1,371,616) |
Cash and cash equivalents - beginning of the period | 1,861,218 | |
Cash and cash equivalents - end of the period | 1,861,218 | 489,602 |
Supplemental disclosure of noncash activities: | ||
Offering costs included in accounts payable | 12,000 | |
Offering costs included in accrued expenses | 90,665 | |
Deferred legal fees | 150,000 | |
Deferred underwriting commissions | 6,300,000 | |
Value of Class B common stock transferred to Anchor Investors at Initial Public Offering | $ 6,834,884 | |
Supplemental cash flow information | ||
Cash paid for taxes | $ 294,000 |
Description of Organization and
Description of Organization and Business Operations | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Organization and Business Operations | Note 1 — Description of Organization and Business Operations Live Oak Crestview Climate Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 12, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. All activity for the period from February 12, 2021 (inception) through December 31, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”) described below, and, subsequent to the Initial Public Offering, the identification and evaluation of prospective acquisition targets for an initial Business Combination, and ongoing administrative and compliance matters. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income investments from the proceeds derived from the Initial Public Offering. The Company’s sponsor is LOCC Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 22, 2021. On September 27, 2021, the Company consummated its Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”) at $ 10.00 per Unit, generating gross proceeds of $ 200.0 million, and incurring offering costs of approximately $ 17.4 million, of which approximately $ 6.3 million and $ 150,000 was for deferred underwriting commissions and deferred legal fees, respectively (Note 5). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,666,666 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $ 1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $ 7.0 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $ 200.0 million ($ 10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80 % of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-business combination company owns or acquires 50 % or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $ 10.00 per Public Share). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. In no event will the Company redeem the Public Shares if such redemption would cause the Company’s Class A common stock to be considered “penny stock” (as such term is defined in Rule 3a51-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15 % or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “Initial Stockholders”) agreed not to propose an amendment to the Amended and Restated Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100 % of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 27, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $ 10.00 . In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $ 10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $ 10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1 % excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1 % of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Liquidity and Capital Resources As of December 31, 2022, the Company had approximately $ 0.5 million in its operating bank account and working capital of approximately $ 0.8 million (investment income classified in the Trust Account is available to the Company for payment of its tax obligations). The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through a payment of $ 25,000 from the Sponsor to purchase the Founder Shares (as defined in Note 4), and the loan proceeds from the Sponsor of approximately $ 125,500 under the Note (as defined in Note 4). The Company repaid the Note in full on September 27, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity needs, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 27, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | Note 2 — Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $ 250,000 . As of December 31, 2022 and 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021 . Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the balance sheets, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Upon completion of the Initial Public Offering, offering costs associated with the Class A common stock issued were charged against the carrying value of the Class A common stock subject to possible redemption and the offering costs associated with the private placement warrants were charged to stockholders’ deficit. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of the Initial Public Offering, 20,000,000 shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. This method would view the end of the reporting period as if it were also the redemption date for the security. Net Loss Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares because the Company assumes a Business Combination to be the most likely outcome. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net loss per share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 11,333,332 shares of Class A common stock, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net loss per share is the same as basic net loss per share for the year ended December 31, 2022 and for the period from February 12, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share of common stock: For The Year Ended December 31, 2022 For The Period From February 12, 2021 Class A Class B Class A Class B Basic and diluted net loss per common stock: Numerator: Allocation of net loss $ ( 391,190 ) $ ( 97,798 ) $ ( 537,695 ) $ ( 445,279 ) Denominator: Basic and diluted weighted average common stock outstanding 20,000,000 5,000,000 5,944,272 4,922,601 Basic and diluted net loss per common stock $ ( 0.02 ) $ ( 0.02 ) $ ( 0.09 ) $ ( 0.09 ) Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2022 and 2021, the Company had a full valuation allowance against the deferred tax assets. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements In June 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statements. |
Initial Public Offering
Initial Public Offering | 11 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Initial Public Offering | Note 3 — Initial Public Offering On September 27, 2021, the Company consummated its Initial Public Offering of 20,000,000 Units, at $ 10.00 per Unit, generating gross proceeds of $ 200.0 million, and incurring offering costs of approximately $ 17.4 million, of which $ 6.3 million and $ 150,000 was for deferred underwriting commissions and deferred legal fees, respectively. Of the 20,000,000 Units sold in the Initial Public Offering, certain investors identified by the Sponsor purchased 2,000,000 Units, and certain investment funds (the “Anchor Investors”) purchased an aggregate of 14,670,000 Units. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $ 11.50 per share, subject to adjustment (see Note 6). |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4 — Related Party Transactions Founder Shares On February 17, 2021, the Sponsor purchased 7,187,500 shares of the Company’s Class B common stock, par value $ 0.0001 per share (the “Founder Shares”), for an aggregate price of $ 25,000 . In June 2021, the Sponsor returned to the Company at no cost an aggregate of 1,437,500 Founder Shares, which were cancelled, resulting in an aggregate of 5,750,000 shares of Class B common stock outstanding. All share and per share amounts have been retroactively restated. The Sponsor agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Founder Shares will represent 20.0 % of the Company’s issued and outstanding shares after the Initial Public Offering. On November 8, 2021, the over-allotment option expired, resulting in 750,000 Founder Shares that were subject to forfeiture to be forfeited. The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the reported closing price of Class A common stock equals or exceeds $ 12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Initial Stockholders with respect to any Founder Shares. In exchange for the Anchor Investors’ participation in the Initial Public Offering as described in Note 3, the Sponsor sold a total of 926,136 Founder Shares to the Anchor Investors. The Company determined that the fair value of these Founder Shares was approximately $ 6.8 million (or $ 7.38 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these Founder Shares, over the price sold to the Anchor Investors, as an expense of the Initial Public Offering resulting in a charge against the carrying value of Class A common stock. Related Party Loans On February 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $ 300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $ 125,500 under the Note and fully repaid on September 27, 2021. Subsequent to the repayment, the facility was no longer available to the Company. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lenders’ discretion, up to $ 1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $ 1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of December 31, 2022 and 2021, the Company had no borrowings under the Working Capital Loans. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,666,666 Private Placement Warrants at a price of $ 1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $ 7.0 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $ 11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Administrative Support Agreement On September 22, 2021, the Company entered into an agreement with an affiliate of the Sponsor, pursuant to which the Company agreed to pay such affiliate a total of $ 15,000 per month for utilities and secretarial and administrative support through the earlier of consummation of the initial Business Combination and the Company’s liquidation. For the year ended December 31, 2022 and for the period from February 12, 2021 (inception) through December 31, 2021, the Company incurred expenses of $ 180,000 and $ 60,000 under this agreement, respectively. As of December 31, 2022 and 2021, the Company had $ 15,000 outstanding, for services in connection with such agreement included in accounts payable on the accompanying balance sheets. The Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 5 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans, if any (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or the warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) were entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. The holders of at least $ 25 million in value of these securities were entitled to demand that the Company file a registration statement covering such securities and to require the Company to effect up to an aggregate of three underwritten offerings of such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed and underwritten offerings subsequent to the completion of the initial Business Combination. The Company will bear the cost of registering these securities. Underwriting Agreement The Company granted the underwriters a 45 -day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. On November 8, 2021 , the over-allotment option expired unexercised. The underwriters agreed not to take any commissions for the 2,000,000 Units sold to certain investors identified by the Sponsor as described in Note 3. The underwriters were entitled to an underwriting discount of $ 0.20 per Unit, or $ 3.6 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, the underwriters will be entitled to a deferred fee of $ 0.35 per Unit, or $ 6.3 million in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Deferred Legal Fees The Company engaged a legal counsel firm for legal advisory services, and the legal counsel agreed to defer their fees until the completion of the initial Business Combination. As of December 31, 2022 and 2021, the Company recorded deferred legal fees of approximately $ 1.6 million and $ 150,000 , respectively, in connection with such services on the accompanying balance sheets. |
Class A Common Stock Subject to
Class A Common Stock Subject to Possible Redemption | 12 Months Ended |
Dec. 31, 2022 | |
Ordinary Shares Subject to Possible Redemption [Abstract] | |
Class A Common Stock Subject to Possible Redemption | Note 6 – Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 250,000,000 shares of Class A common stock with a par value of $ 0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of December 31, 2022 and 2021, there were 20,000,000 shares of Class A common stock outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the balance sheets. The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table: Gross proceeds from Initial Public Offering $ 200,000,000 Less: Fair value of Public Warrants at issuance ( 6,933,330 ) Offering costs allocated to Class A common stock ( 16,752,660 ) Plus: Accretion on Class A common stock subject to possible redemption 23,685,990 Class A common stock subject to possible redemption, December 31, 2021 200,000,000 Increase in redemption value of Class A common stock subject to possible redemption amount 1,963,110 Class A common stock subject to possible redemption, December 31, 2022 $ 201,963,110 |
Stockholders' Deficit
Stockholders' Deficit | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Deficit | Note 7 — Stockholders’ Deficit Preferred Stock— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $ 0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2022 and 2021, there were no shares of preferred stock issued or outstanding. Class A Common Stock— The Company is authorized to issue 250,000,000 shares of Class A common stock with a par value of $ 0.0001 per share. As of December 31, 2022 and 2021, there were 20,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and were classified outside of permanent equity on the balance sheets. Class B Common Stock — The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $ 0.0001 per share. As of December 31, 2022 and 2021, there were 5,000,000 shares of Class B common stock issued and outstanding Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all other matters submitted to a vote of the stockholders except as required by law, provided, that the holders of Class B common stock will be entitled to vote as a separate class to increase the authorized number of shares of Class B common stock. The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Class B common stock will equal, in the aggregate, on an as-converted basis, 20 % of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering, plus the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Class B common stock will never occur on a less than one-for-one basis . |
Warrants
Warrants | 12 Months Ended |
Dec. 31, 2022 | |
Warrant Liability [Abstract] | |
Warrants | Note 8—Warrants As of December 31, 2022 and 2021, the Company had 6,666,666 Public Warrants and 4,666,666 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the shares of the Class A common stock issuable upon exercise of the warrants. The Company has also agreed to use its commercially reasonable efforts to cause the registration statement to become effective and to maintain a current prospectus relating to those shares of the Class A common stock until the warrants expire or are redeemed. If a registration statement covering the shares of the Class A common stock issuable upon exercise of the warrants is not effective by the 60 th business day after the closing of the initial Business Combination, warrant-holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The warrants have an exercise price of $ 11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity- linked securities in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $ 9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the average last reported sale price of the common stock as reported during the 10 trading day period ending on the trading day prior to the date of the consummation of the initial business combination (such price, the “Market Value”) is below $ 9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the higher of the Market Value and the Newly Issued Price, and the $ 18.00 per share redemption trigger price described under “Redemption of Public Warrants” will be adjusted (to the nearest cent) to be equal to 180 % of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable. Redemption of Public Warrants Once the warrants become exercisable, the Company may call the Public Warrants for redemption for cash: • in whole and not in part; • at a price of $ 0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant-holder; and • if, and only if, the last reported sale price of the Class A common stock has been at least $ 18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on each of 20 trading days within the 30 -trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant-holders. The Company will not redeem the Public Warrants as described above unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising holder to pay the exercise price for each warrant being exercised. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants may not be redeemed by the Company and the holders of Private Placement Warrants may elect to exercise the warrants on a “cashless” basis. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 9 — Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: December 31, 2022 Description Quoted Prices Significant Other Significant Other Assets: Investments held in Trust Account - Money Market Fund $ 202,487,473 $ — $ — December 31, 2021 Description Quoted Prices Significant Other Significant Other Assets: Investments held in Trust Account - Money Market Fund $ 200,004,310 $ — $ — Level 1 assets include investments in a money market fund that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers to/from Levels 1, 2, and 3 during the period from February 12, 2021 (inception) through December 31 2022. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 10 — Income Taxes The Company’s taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative expenses are generally considered start-up costs and are not currently deductible. The income tax provision (benefit) consists of the following: For the Year Ended December 31, 2022 For The Period from February 12, Current Federal $ 564,120 $ 10,343 State — — Deferred Federal 548,342 196,082 State — — Valuation allowance ( 548,342 ) ( 206,425 ) Income tax provision $ 564,120 $ — The Company’s net deferred tax assets are as follows: December 31, 2022 December 31, 2021 Deferred tax assets: Start-up/Organization costs $ 744,424 $ 196,082 Net operating loss carryforwards — 10,343 Total deferred tax assets 744,424 206,425 Valuation allowance ( 744,424 ) ( 206,425 ) Deferred tax asset, net of allowance $ — $ — In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. At December 31, 2022 and 2021, the valuation allowance was approximately $ 744 ,000 and $ 206 ,000, respectively. There were no unrecognized tax benefits as of December 31, 2022 and 2021. No amounts were accrued for the payment of interest and penalties at December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows: For the Year Ended December 31, 2022 For The Period from February 12, Statutory federal income tax rate 21.0 % 21.0 % Change in valuation allowance 729.8 % ( 21.0 )% Income tax expense 750.8 % 0.0 % |
Subsequent Events
Subsequent Events | 11 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 11 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $ 250,000 . As of December 31, 2022 and 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021 |
Investments Held in the Trust Account | Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the balance sheets, primarily due to their short-term nature. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Upon completion of the Initial Public Offering, offering costs associated with the Class A common stock issued were charged against the carrying value of the Class A common stock subject to possible redemption and the offering costs associated with the private placement warrants were charged to stockholders’ deficit. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of the Initial Public Offering, 20,000,000 shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. This method would view the end of the reporting period as if it were also the redemption date for the security. |
Net Loss Per Share of Common Stock | Net Loss Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares because the Company assumes a Business Combination to be the most likely outcome. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net loss per share does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 11,333,332 shares of Class A common stock, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net loss per share is the same as basic net loss per share for the year ended December 31, 2022 and for the period from February 12, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share of common stock: For The Year Ended December 31, 2022 For The Period From February 12, 2021 Class A Class B Class A Class B Basic and diluted net loss per common stock: Numerator: Allocation of net loss $ ( 391,190 ) $ ( 97,798 ) $ ( 537,695 ) $ ( 445,279 ) Denominator: Basic and diluted weighted average common stock outstanding 20,000,000 5,000,000 5,944,272 4,922,601 Basic and diluted net loss per common stock $ ( 0.02 ) $ ( 0.02 ) $ ( 0.09 ) $ ( 0.09 ) |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2022 and 2021, the Company had a full valuation allowance against the deferred tax assets. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statements. |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share of common stock: For The Year Ended December 31, 2022 For The Period From February 12, 2021 Class A Class B Class A Class B Basic and diluted net loss per common stock: Numerator: Allocation of net loss $ ( 391,190 ) $ ( 97,798 ) $ ( 537,695 ) $ ( 445,279 ) Denominator: Basic and diluted weighted average common stock outstanding 20,000,000 5,000,000 5,944,272 4,922,601 Basic and diluted net loss per common stock $ ( 0.02 ) $ ( 0.02 ) $ ( 0.09 ) $ ( 0.09 ) |
Class A Common Stock Subject _2
Class A Common Stock Subject to Possible Redemption (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Ordinary Shares Subject to Possible Redemption [Abstract] | |
Schedule of Reconciliation of Shares Subject To Possible Redemption Reflected in The Balance Sheet | The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table: Gross proceeds from Initial Public Offering $ 200,000,000 Less: Fair value of Public Warrants at issuance ( 6,933,330 ) Offering costs allocated to Class A common stock ( 16,752,660 ) Plus: Accretion on Class A common stock subject to possible redemption 23,685,990 Class A common stock subject to possible redemption, December 31, 2021 200,000,000 Increase in redemption value of Class A common stock subject to possible redemption amount 1,963,110 Class A common stock subject to possible redemption, December 31, 2022 $ 201,963,110 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Financial Asset Measured at Fair Value on Recurring Basis | The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: December 31, 2022 Description Quoted Prices Significant Other Significant Other Assets: Investments held in Trust Account - Money Market Fund $ 202,487,473 $ — $ — December 31, 2021 Description Quoted Prices Significant Other Significant Other Assets: Investments held in Trust Account - Money Market Fund $ 200,004,310 $ — $ — |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Summary of Income Tax Provision (Benefits) | The income tax provision (benefit) consists of the following: For the Year Ended December 31, 2022 For The Period from February 12, Current Federal $ 564,120 $ 10,343 State — — Deferred Federal 548,342 196,082 State — — Valuation allowance ( 548,342 ) ( 206,425 ) Income tax provision $ 564,120 $ — |
Summary of Net Deferred Tax Assets | The Company’s net deferred tax assets are as follows: December 31, 2022 December 31, 2021 Deferred tax assets: Start-up/Organization costs $ 744,424 $ 196,082 Net operating loss carryforwards — 10,343 Total deferred tax assets 744,424 206,425 Valuation allowance ( 744,424 ) ( 206,425 ) Deferred tax asset, net of allowance $ — $ — |
Summary of Reconciliation of the Statutory Federal Income Tax Rate | A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows: For the Year Ended December 31, 2022 For The Period from February 12, Statutory federal income tax rate 21.0 % 21.0 % Change in valuation allowance 729.8 % ( 21.0 )% Income tax expense 750.8 % 0.0 % |
Description of Organization a_2
Description of Organization and Business Operations - Additional Information (Detail) - USD ($) | 11 Months Ended | 12 Months Ended | |
Sep. 27, 2021 | Dec. 31, 2021 | Dec. 31, 2022 | |
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Proceeds received from initial public offering, gross | $ 200,000,000 | ||
Adjustments to additional paid in capital, stock issued, issuance costs | 617,213 | ||
Payments to acquire restricted investments | 200,000,000 | ||
Term of restricted investments | 185 days | ||
Percentage of public shares that can be transferred without any restriction | 15% | ||
Percentage of public shares to be redeemed in case business combination is not consummated | 100% | ||
Period within which business combination shall be consummated from the consummation of initial public offer | 24 months | ||
Percentage of excise tax on fair value of stock repurchase | 1% | ||
Number of days within which public shares shall be redeemed | 10 days | ||
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities | $ 100,000 | ||
Per share value of restricted assets | $ 10 | ||
Share price | $ 10 | ||
Cash | $ 500,000 | ||
Net working capital | 800,000 | ||
Stock issued during period, value, issued for services | 7,000,000 | ||
Proceeds from note payable to related party | 125,500 | ||
Deferred legal fees | 150,000 | $ 1,576,175 | |
Sponsor [Member] | Promissory Note [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Stock issued during period, value, issued for services | 25,000 | ||
Proceeds from note payable to related party | $ 125,500 | ||
Minimum [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Prospective assets of acquire as a percentage of fair value of assets in the trust account | 80% | ||
Equity method investment, ownership percentage | 50% | ||
U.S. Federal | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Inflation Reduction Act 2022 federal excise tax on repurchases of public traded stock | 1% | ||
Private Placement Warrants [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Sale of stock, price per share | $ 1.50 | ||
Class of warrant or right, outstanding | 4,666,666 | 4,666,666 | 4,666,666 |
Proceeds from issuance of warrants | $ 7,000,000 | ||
IPO [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Payments to acquire restricted investments | $ 200,000,000 | ||
Restricted investment per share value | $ 10 | ||
IPO [Member] | Private Placement Warrants [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Sale of stock, price per share | $ 1.50 | ||
Class of warrant or right, outstanding | 4,666,666 | ||
Proceeds from issuance of warrants | $ 7,000,000 | ||
Common Class A [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Share price | $ 9.20 | ||
Common Class A [Member] | IPO [Member] | |||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||
Stock shares issued during the period shares | 20,000,000 | ||
Sale of stock, price per share | $ 10 | ||
Proceeds received from initial public offering, gross | $ 200,000,000 | ||
Adjustments to additional paid in capital, stock issued, issuance costs | 17,400,000 | ||
Deferred underwriting commission | 6,300,000 | ||
Deferred legal fees | $ 150,000 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies -Schedule of Earnings Per Share Basic And Diluted (Detail) - USD ($) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
Numerator: | ||
Allocation of net loss | $ (982,974) | $ (488,988) |
Net Loss Per Share Class A Common Stock [Member] | ||
Numerator: | ||
Allocation of net loss | $ (537,695) | $ (391,190) |
Denominator: | ||
Basic weighted average common stock outstanding | 5,944,272 | 20,000,000 |
Diluted weighted average common stock outstanding | 5,944,272 | 20,000,000 |
Basic net loss per common stock | $ (0.09) | $ (0.02) |
Diluted net loss per common stock | $ (0.09) | $ (0.02) |
Net Loss Per Share Class B Common Stock [Member] | ||
Numerator: | ||
Allocation of net loss | $ (445,279) | $ (97,798) |
Denominator: | ||
Basic weighted average common stock outstanding | 4,922,601 | 5,000,000 |
Diluted weighted average common stock outstanding | 4,922,601 | 5,000,000 |
Basic net loss per common stock | $ (0.09) | $ (0.02) |
Diluted net loss per common stock | $ (0.09) | $ (0.02) |
Basis of Presentation and Sum_5
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Cash, FDIC insured amount | $ 250,000 | |
Cash equivalents, at carrying value | $ 0 | $ 0 |
Term of restricted investments | 185 days | |
Unrecognized tax benefits | $ 0 | 0 |
Unrecognized tax benefits, income tax penalties and interests accrued | $ 0 | $ 0 |
Class A Common Stock Subject To Possible Redemption [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Temporary equity shares Outstanding | 20,000,000 | |
Common Class A [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Temporary equity shares Outstanding | 20,000,000 | 20,000,000 |
Common Class A [Member] | Warrant [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share, amount | 11,333,332 |
Initial Public Offering - Addit
Initial Public Offering - Additional Information (Detail) - USD ($) | 11 Months Ended | ||
Sep. 27, 2021 | Dec. 31, 2021 | Dec. 31, 2022 | |
Class of Stock [Line Items] | |||
Initial Public Offering, Gross proceed | $ 200,000,000 | ||
Initial Public Offering, Offering cost | 617,213 | ||
Initial Public Offering, Deferred legal fees | $ 150,000 | $ 1,576,175 | |
Anchor Investors [Member] | |||
Class of Stock [Line Items] | |||
Initial Public Offering, Price per share | $ 7.38 | ||
IPO [Member] | Common Class A [Member] | |||
Class of Stock [Line Items] | |||
Initial Public Offering, Units | 20,000,000 | ||
Initial Public Offering, Price per share | $ 11.50 | ||
Initial Public Offering, Gross proceed | $ 200,000,000 | ||
Initial Public Offering, Price per share | $ 10 | ||
Initial Public Offering, Offering cost | $ 17,400,000 | ||
Initial Public Offering, Deferred underwriting commission | 6,300,000 | ||
Initial Public Offering, Deferred legal fees | $ 150,000 | ||
IPO [Member] | Sponsor [Member] | |||
Class of Stock [Line Items] | |||
Initial Public Offering, Purchased units | 2,000,000 | ||
IPO [Member] | Anchor Investors [Member] | |||
Class of Stock [Line Items] | |||
Initial Public Offering, Purchased units | 14,670,000 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) | 1 Months Ended | 11 Months Ended | 12 Months Ended | |||||
Nov. 08, 2021 | Sep. 27, 2021 | Sep. 22, 2021 | Feb. 17, 2021 | Jun. 30, 2021 | Dec. 31, 2021 | Dec. 31, 2022 | Feb. 12, 2021 | |
Related Party Transaction [Line Items] | ||||||||
Stock issued during period, value, issued for services | $ 7,000,000 | |||||||
Percentage of common stock issued and outstanding | 20% | |||||||
Share price | $ 10 | |||||||
Proceeds from note payable to related party | $ 125,500 | |||||||
Working capital loans convertible into equity warrants | $ 1,500,000 | |||||||
Class of warrant or right, exercise price of warrants or rights | $ 11.50 | |||||||
Private Placement Warrants [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Sale of stock, price per share | $ 1.50 | |||||||
Class of warrant or right, outstanding | 4,666,666 | 4,666,666 | 4,666,666 | |||||
Proceeds from issuance of warrants | $ 7,000,000 | |||||||
Class of warrant or right, exercise price of warrants or rights | $ 11.50 | |||||||
Class of warrant or right, number of securities called by each warrant or right | 1 | |||||||
Private Placement Warrants [Member] | From The Completion Of Business Combination [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Period after which the warrants are exercisable | 30 days | |||||||
Common Class B [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | ||||||
Common stock shares outstanding | 5,000,000 | 5,000,000 | ||||||
Common Class A [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | ||||||
Common stock shares outstanding | 20,000,000 | 20,000,000 | ||||||
Share price | $ 9.20 | |||||||
Administrative Support Agreement [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Related party transaction, amounts of transaction | $ 15,000 | |||||||
Related party transaction, selling, general and administrative expenses from transactions with related party | $ 60,000 | $ 180,000 | ||||||
Due to related parties | 15,000 | $ 15,000 | ||||||
Sponsor [Member] | Over-Allotment Option [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Shares issued, shares, share-based payment arrangement, forfeited | 750,000 | |||||||
Percentage of common stock issued and outstanding | 20% | |||||||
Sponsor [Member] | Common Class B [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during period, shares, issued for services | 7,187,500 | |||||||
Common stock par or stated value per share | $ 0.0001 | |||||||
Stock issued during period, value, issued for services | $ 25,000 | |||||||
Stock redeemed or called during period, shares | 1,437,500 | |||||||
Common stock shares outstanding | 5,750,000 | |||||||
Sponsor [Member] | Promissory Note [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during period, value, issued for services | 25,000 | |||||||
Debt instrument, face amount | $ 300,000 | |||||||
Proceeds from note payable to related party | 125,500 | |||||||
Sponsor [Member] | Working Capital Loan [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Debt instrument, convertible, conversion price | $ 1.50 | |||||||
Bank overdrafts | $ 0 | $ 0 | ||||||
Founder Shares [Member] | Common Class A [Member] | Restriction on Transfer of Sponsor Shares [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Lock in period of shares | 1 year | |||||||
Share price | $ 12 | |||||||
Number of trading days for determining the share price | 20 days | |||||||
Number of consecutive trading days for determining the share price | 30 days | |||||||
Waiting period after which the share trading days are considered | 150 days | |||||||
Anchor Investors [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during period, shares, issued for services | 926,136 | |||||||
Stock issued during period, value, issued for services | $ 6,800,000 | |||||||
Sale of stock, price per share | $ 7.38 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Other Commitments [Line Items] | ||
Registration payment arrangement, accrual carrying value | $ 25,000,000 | |
Deferred legal fees | $ 1,576,175 | $ 150,000 |
Underwriting Agreement [Member] | Over-Allotment Option [Member] | ||
Other Commitments [Line Items] | ||
Share-based payment award, expiration period | 45 days | |
Stock shares issued during the period shares | 3,000,000 | |
Share-based payment award, expiration date | Nov. 08, 2021 | |
Underwriting discount per share | $ 0.20 | |
Payment of underwriting discount | $ 3,600,000 | |
Deferred underwriting discount per share | $ 0.35 | |
Deferred underwriting commission | $ 6,300,000 | |
Underwriting Agreement [Member] | Over-Allotment Option [Member] | Sponsor [Member] | ||
Other Commitments [Line Items] | ||
Stock shares issued during the period shares | 2,000,000 |
Class A Common Stock Subject _3
Class A Common Stock Subject to Possible Redemption - Additional Information (Detail) - Common Class A [Member] - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Ordinary Shares Subject to Possible Redemption [Line Items] | ||
Common Stock, Shares Authorized | 250,000,000 | 250,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Temporary Equity, Shares Outstanding | 20,000,000 | 20,000,000 |
Class A Common Stock Subject _4
Class A Common Stock Subject to Possible Redemption - Schedule of Reconciliation of Shares Subject To Possible Redemption Reflected in The Balance Sheet (Detail) - USD ($) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
Gross proceeds from Initial Public Offering | $ (200,000,000) | |
Increase in redemption value of Class A common stock subject to possible redemption amount | (23,685,991) | $ (1,963,110) |
Class A Common Stock Subject To Possible Redemption [Member] | ||
Gross proceeds from Initial Public Offering | 200,000,000 | |
Fair value of Public Warrants at issuance | (6,933,330) | |
Offering costs allocated to Class A common stock | (16,752,660) | |
Accretion on Class A common stock subject to possible redemption amount | 23,685,990 | |
Increase in redemption value of Class A common stock subject to possible redemption amount | (1,963,110) | |
Class A common stock subject to possible redemption | $ 200,000,000 | $ 201,963,110 |
Stockholders' Deficit - Additi
Stockholders' Deficit - Additional Information (Detail) - $ / shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Class of Stock [Line Items] | ||
Preferred stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Preferred stock shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock shares outstanding | 0 | 0 |
Percentage of common stock issued and outstanding | 20% | |
Common stock, conversion basis | one-for-one basis | |
Common Class A [Member] | ||
Class of Stock [Line Items] | ||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 250,000,000 | 250,000,000 |
Common stock shares issued | 20,000,000 | 20,000,000 |
Common stock shares outstanding | 20,000,000 | 20,000,000 |
Common Class B [Member] | ||
Class of Stock [Line Items] | ||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 20,000,000 | 20,000,000 |
Common stock shares issued | 5,000,000 | 5,000,000 |
Common stock shares outstanding | 5,000,000 | 5,000,000 |
Warrants - Additional Informati
Warrants - Additional Information (Detail) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Sep. 27, 2021 | |
Warrant Liability [Line Items] | |||
Number of days after consummation of business combination within which the securities shall be registered | 15 days | ||
Number of days after which business combination within which securities registration shall be effective | 60 days | ||
Class of warrant or right, exercise price of warrants or rights | $ 11.50 | ||
Warrants and rights outstanding, term | 5 years | ||
Share price | $ 10 | ||
Common Class A [Member] | |||
Warrant Liability [Line Items] | |||
Share price | $ 9.20 | ||
Proceeds from equity used for funding business combination as a percentage of the total | 60% | ||
Number of consecutive trading days for determining volume weighted average price of shares | 10 days | ||
Public Warrants [Member] | |||
Warrant Liability [Line Items] | |||
Class of warrant or right, outstanding | 6,666,666 | 6,666,666 | |
Class of warrants or rights redemption price per unit | $ 0.01 | ||
Minimum notice period to be given to the holders of warrants | 30 days | ||
Public Warrants [Member] | Common Class A [Member] | |||
Warrant Liability [Line Items] | |||
Share price | $ 18 | ||
Number of consecutive trading days for determining the share price | 20 days | ||
Number of trading days for determining the share price | 30 days | ||
Public Warrants [Member] | Common Class A [Member] | Adjusted Exercise Price One [Member] | |||
Warrant Liability [Line Items] | |||
Volume weighted average price of shares | $ 9.20 | ||
Adjusted exercise price of warrants as a percentage of newly issued price | 115% | ||
Public Warrants [Member] | Common Class A [Member] | Adjusted Exercise Price Two [Member] | |||
Warrant Liability [Line Items] | |||
Volume weighted average price of shares | $ 18 | ||
Adjusted exercise price of warrants as a percentage of newly issued price | 180% | ||
Public Warrants [Member] | From The Completion Of Business Combination [Member] | |||
Warrant Liability [Line Items] | |||
Period after which the warrants are exercisable | 30 days | ||
Private Placement Warrants [Member] | |||
Warrant Liability [Line Items] | |||
Class of warrant or right, outstanding | 4,666,666 | 4,666,666 | 4,666,666 |
Class of warrant or right, exercise price of warrants or rights | $ 11.50 | ||
Private Placement Warrants [Member] | Common Class A [Member] | |||
Warrant Liability [Line Items] | |||
Class of warrants or rights lock in period | 30 days | ||
Private Placement Warrants [Member] | From The Completion Of Business Combination [Member] | |||
Warrant Liability [Line Items] | |||
Period after which the warrants are exercisable | 30 days |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of Financial Asset Measured at Fair Value on Recurring Basis (Detail) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Assets [Abstract] | ||
Investments held in Trust Account - Money Market Fund | $ 202,487,473 | $ 200,004,310 |
Level 1 [Member] | Money Market Funds [Member] | ||
Assets [Abstract] | ||
Investments held in Trust Account - Money Market Fund | 202,487,473 | 200,004,310 |
Level 2 [Member] | Money Market Funds [Member] | ||
Assets [Abstract] | ||
Investments held in Trust Account - Money Market Fund | ||
Level 3 [Member] | Money Market Funds [Member] | ||
Assets [Abstract] | ||
Investments held in Trust Account - Money Market Fund |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Income Tax Disclosure [Abstract] | ||
Valuation allowance | $ 744,424 | $ 206,425 |
Unrecognized tax benefits | 0 | 0 |
Unrecognized tax benefits income tax penalties and interest accrued | $ 0 | $ 0 |
Income Taxes - Summary of Incom
Income Taxes - Summary of Income Tax Provision (Benefits) (Detail) - USD ($) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
Current | ||
Federal | $ 10,343 | $ 564,120 |
State | 0 | 0 |
Deferred | ||
Federal | 196,082 | 548,342 |
State | 0 | 0 |
Valuation allowance | (206,425) | (548,342) |
Income tax provision | $ 0 | $ 564,120 |
Income Taxes - Summary of Net D
Income Taxes - Summary of Net Deferred Tax Assets (Detail) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred tax assets: | ||
Start-up/Organization costs | $ 744,424 | $ 196,082 |
Net operating loss carryforwards | 0 | 10,343 |
Total deferred tax assets | 744,424 | 206,425 |
Valuation allowance | (744,424) | (206,425) |
Deferred tax asset, net of allowance | $ 0 | $ 0 |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of the Statutory Federal Income Tax Rate (Benefit) (Detail) | 11 Months Ended | 12 Months Ended |
Dec. 31, 2021 | Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||
Statutory federal income tax rate | 21% | 21% |
Change in valuation allowance | (21.00%) | 729.80% |
Income tax expense | 0% | 750.80% |